ConductScience.org, home
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
API referenceFor AI assistants

Trial · NCT02418000

Results by group101

Each measurement the trial posted, group by group, in the words and numbers it posted.

21 to 40 of 101

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Pharmacokinetic Profile of E6201 in Plasma: CmaxE6201 320 mg/m^2 Twice Weekly1681.12Standard Deviation 5.6ng/mL
Pharmacokinetics of E6201 in Plasma: TmaxE6201 240 mg/m^2 Weekly2.34Standard Deviation 7.5h
Pharmacokinetics of E6201 in Plasma: TmaxE6201 320 mg/m^2 Weekly4.10Standard Deviation 95.4h
Pharmacokinetics of E6201 in Plasma: TmaxE6201 160 mg/m^2 Twice Weekly2.17Standard Deviation 0.9h
Pharmacokinetics of E6201 in Plasma: TmaxE6201 240 mg/m^2 Twice Weekly2.32Standard Deviation 6.8h
Pharmacokinetics of E6201 in Plasma: TmaxE6201 320 mg/m^2 Twice Weekly2.18Standard Deviation 4.2h
Pharmacokinetic Profile of E6201 in Plasma: AUCTE6201 240 mg/m^2 Weekly3797.76Standard Deviation 20.6h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCTE6201 320 mg/m^2 Weekly8135.24Standard Deviation 88.0h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCTE6201 160 mg/m^2 Twice Weekly3034.10Standard Deviation 69.8h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCTE6201 240 mg/m^2 Twice Weekly2796.73Standard Deviation 50.3h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCTE6201 320 mg/m^2 Twice Weekly6082.79Standard Deviation 23.0h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCIE6201 240 mg/m^2 Weekly3871.83Standard Deviation 21.7h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCIE6201 320 mg/m^2 Weekly2506.90Standard Deviation 56.0h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCIE6201 160 mg/m^2 Twice Weekly1853.13Standard Deviation 1.1h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCIE6201 240 mg/m^2 Twice Weekly2215.63Standard Deviation 59.0h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: AUCIE6201 320 mg/m^2 Twice Weekly6388.31Standard Deviation 25.0h.ng/mL
Pharmacokinetic Profile of E6201 in Plasma: T1/2E6201 240 mg/m^2 Weekly3.78Standard Deviation 88.0h
Pharmacokinetic Profile of E6201 in Plasma: T1/2E6201 320 mg/m^2 Weekly2.71Standard Deviation 87.5h
Pharmacokinetic Profile of E6201 in Plasma: T1/2E6201 160 mg/m^2 Twice Weekly3.20Standard Deviation 43.6h
Pharmacokinetic Profile of E6201 in Plasma: T1/2E6201 240 mg/m^2 Twice Weekly1.66Standard Deviation 4.5h

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02418000/results?page=2

API referenceFor AI assistants